SURMOUNT-2, which included participants with type 2 diabetes, showed weight reductions of 12.8% to 15.7% with tirzepatide versus 3.2% with placebo
If HCPCS codes are added to or deleted from an APC and, after ( recalibrating its relative payment weight, holding its unadjusted copayment amount constant results in a decrease in the coinsurance percentage for the reconfigured APC, the copayment amount would not change (unless retaining the copayment amount would result in a coinsurance rate less than 20 percent)
We understand that dealing with serious health complications related to prescription medications can be overwhelming, stressful, and deeply personal
Researchers defined MALO as decompensated cirrhosis, hepatocellular carcinoma, liver transplantation or related death and compared parametric estimates of 10-year risk among initiators vs
Conversely, symptoms of hypotension (low blood pressure) should also prompt medical review
If the answer to any of these questions is yes, inform your provider before the next scheduled dose increase
